Who are contraindicated in using Cabergoline?

Cabergoline (Cabergoline) is a dopamine receptor agonist commonly used to treat hyperprolactinemia, Parkinson's disease and other diseases. It can effectively inhibit the secretion of prolactin (Prolactin). However, although cabergoline has clear efficacy, not all people are suitable for its use. It has clear clinical contraindications to ensure the safety and effectiveness of the drug.

This drug is contraindicated in people who are allergic to cabergoline or ergot drugs (such as bromocriptine). This type of medicine may cause allergic reactions, such as rash, difficulty breathing, or severe anaphylactic shock. If such a situation occurs, the medicine should be stopped immediately and emergency treatment should be received. In addition, patients with a history of severe allergies to drug excipients should avoid use.

Cabergoline should be contraindicated in patients with severe valvular heart disease. Studies have found that long-term use of cabergoline may cause heart valve thickening or regurgitation, especially in patients with Parkinson's disease at higher doses. Therefore, cardiac ultrasound examination is usually required to assess valve function before use and should also be monitored regularly during treatment.

Cabergoline is also not suitable for people with severe liver dysfunction. Because the drug is mainly metabolized by the liver, hepatic insufficiency will affect drug clearance, which may lead to increased blood drug concentration and increase the risk of side effects. In addition, patients with active gastric ulcers, bleeding tendencies, or severe mental illness (such as schizophrenia) should also use this drug with caution or disable it to avoid aggravating the original disease.

In summary, although cabergoline is an effective drug for the treatment of hyperprolactinemia and other diseases, its use must strictly comply with the contraindicated population guidance, and special attention should be paid to heart valve disease, allergic history, liver function status, and mental state. Doctors should evaluate the patient's physical condition in detail before prescribing this drug to ensure the individualization and safety of the medication.

Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets